Meet the 2015 judges

The multidisciplinary panel of judges comprised recognised clinicians, GPs, nurses, pharmacists, commissioners and patient representatives working in the field of Hepatitis C.

Judges were:

Dr John Dillon is a Clinical Reader in Hepatology and Gastroenterology and a principle investigator in the Medical Research Institute, Ninewells Hospital and University of Dundee. He is also an Honorary Consultant with NHS Tayside, leading a busy general hepatology service and a research group. He graduated in medicine from St Georges' Hospital Medical School, University of London and subsequently gained his MD based on research performed in the University of Edinburgh, while a lecturer in Gastroenterology and Hepatology.

His research interests include; new pathways of care for patients with abnormal LFTs and also for PWID infected with HCV, new therapies for HCV infection, as well as novel diagnostics and treatments for NAFLD. His research activities stretch from the bench to the bedside and out into the community. He has published over 100 peer reviewed original research papers. He is clinical lead for blood borne viruses in NHS Tayside; he chairs the Scottish HCV Action Plan Clinical Leads Group and is a member of the Scottish Governments Ministerial advisory board for blood bourne viruses and sexual health.

Previously Dr Dillon chaired the testing treatment and care working group of phase 1 of the Scottish Government HCV Action Plan, twice he lead the development group of the UK consensus guidelines for HCV and twice has chaired the Hepatitis C SIGN guideline development group.

Geoffrey Dusheiko, MD, MB,BCh, is Emeritus Professor of Medicine at the Royal Free Hospital and University College School of Medicine, London, UK. He earned his bachelor of medicine, bachelor of surgery degree from the University of Witwatersrand in Johannesburg, South Africa. After graduating, he completed his internship at Baragwanath Hospital in Johannesburg and his residency at Johannesburg Hospital. His fellowships were conducted at the Johannesburg Hospital Liver Unit and the National Institutes of Health in Maryland and the University of Minnesota (United States).

Dr. Dusheiko's research interests include the management and treatment of hepatitis B and C and small hepatocellular carcinoma; he has a special interest in research in viral hepatitis, focused on viral genotyping, applied molecular virology, the natural history of chronic viral hepatitis, and antiviral therapies. He has served on editorial boards for the Journal of Viral Hepatitis, Hepatology, and Best Practice and Research: Clinical Gastroenterology, GUT among others, and is the author of more than 330 published articles. He is currently a co-editor of Alimentary Pharmacology and Therapeutics.

A member of several organizations, including IASL, AASLD, and EASL, he is a fellow of the Royal College of Physicians, the Royal College of Physicians of South Africa, and the Royal College of Physicians of Edinburgh. He served as Educational Councilor on the Governing Board of the European Association for the Study of the Liver for the past 4 years. He is a director of the Skipton Fund and is a guidelines writer for the WHO.  

Liz Farrington qualified in 1995 with a BSc in Nursing Studies and went on to work in a variety of hospitals around the UK, predominantly in GI surgery. Liz developed a specific interest in Hepatology whilst working in New Zealand with patients undergoing hepatic surgery and, on moving to Cornwall in 2003, started working with Hepatitis C treatment patients as a specialist nurse. In 2006 she completed an MSc in Advanced Healthcare Practice and in 2009 qualified as an independent nurse prescriber.

This has allowed Liz to develop her practice as an advanced nurse practitioner, working autonomously with patients with a variety of hepatological conditions, many of whom are undiagnosed. She is an independent referrer for radiological and endoscopic procedures and fully trained in the performance of ultrasound guided percutaneous liver biopsy.

Liz is passionate about liver disease and works closely with the Department of Health, Royal College of Nursing and British Liver Trust to enhance awareness and understanding of the disorder, whilst focusing on strategic developments to ensure quality and equity in healthcare delivery. She is an editorial board member for Gastrointestinal Nursing Journal liver supplement and in 2014 was acknowledged for her contribution to the Lancet publication addressing the liver disease crisis in the UK.

In 2004 Helen qualified as an RGN in her home County of Cornwall. She worked at the Royal Cornwall Hospital as a surgical nurse on the vascular ward and the surgical admissions unit.

From 2007 – 2012, Helen worked with Cornwall Drug and Alcohol Team running a successful HCV treatment service in primary care offering treatment and support to a community that can feel isolated, marginalised and socially excluded.  In 2012 she joined Addaction in a new developing role ensuring best practice, enhancing awareness, BBV screening and developing a robust vaccination programme. Helen currently leads on BBV services across Cornwall and Devon.  In addition she is a non-medical prescriber.

In 2014, Helen was presented with a ‘highly commended’ certificate on behalf of the team for ‘best treatment pathway initiative group’ for the Quality in Care Hepatitis C awards. This year Helen was awarded the Queens’ Nurse Title for recognition for her work in the community.

Annelies McCurley has a BSC hons Nursing Sciences and a post grade certificate in endoscopy and related procedures from Queens University, Belfast.

She has been employed by the Northern Ireland Regional Hepatitis B&C Managed Clinical Network Manager since April 2010. She has led on Northern Ireland – Hepatitis C ‘Mind the Gap project’ – The intervention to reduce the drop-off between those patients newly diagnosed in Northern Ireland with Hepatitis C and those referred for assessment.

Prior to this she also worked as GRS Project Manager for the Belfast Trust, making use of a national endoscopy service evaluation tool that evaluates multiple components of endoscopy service from ‘clinical quality’ to the ‘quality of the patient experience’. This was done to prepare the endoscopy units for the implementation of the UK national bowel cancer screening programme which commenced in Northern Ireland in 2010.

Susan works as Training and Development Manager at the Hepatitis C Trust. The Trust is the only UK-wide charity focused on hepatitis C, supporting not only people living with the virus, but also those at risk of infection.  It is led and driven by people with personal experience of hepatitis C and Susan has had hepatitis C for several decades.

Susan delivers training to support people working in drug and addiction services, prisons, charities, healthcare settings, community pharmacies, mental health and homeless services. Susan also acts as a patient representative on various hepatitis C related committees such as the Liver Patient Transplant Consortium.

Dr Rehman is currently employed as a Consultant Physician at Bradford Royal infirmary and as a GP trainee on the Bradford Vocational Training Scheme. 

He graduated from the University of Newcastle in 1998 and completed his postgraduate training in Gastroenterology (sub-specialty of Hepatology) and General Internal Medicine in West Yorkshire gaining his CCT in 2009, having spent a significant proportion of his training on the regional Liver Transplant Unit.

He will shortly qualify as a General Practitioner in August 2015, allowing him to work as a Consultant and General Practitioner.

His main clinical research interest is in viral hepatitis, particularly with reference to ethnic minorities in the UK. He has completed a number of projects which focus on epidemiology and treatment outcomes in the South-Asian communities based in Yorkshire.


  • KEY DATES FOR 2017 TO BE ANNOUNCED
QiC Hepatitis C is supported by: